Profile for Canada Patent: 2957588
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 2957588
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,179,119 | Aug 29, 2035 | Vanda Pharms Inc | HETLIOZ | tasimelteon |
| 10,179,119 | Aug 29, 2035 | Vanda Pharms Inc | HETLIOZ LQ | tasimelteon |
| 11,266,622 | Aug 29, 2035 | Vanda Pharms Inc | HETLIOZ | tasimelteon |
| 11,266,622 | Aug 29, 2035 | Vanda Pharms Inc | HETLIOZ LQ | tasimelteon |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
